Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
10.2967/jnumed.119.226993 · doi-reference
Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart
10.1161/circresaha.118.314030 · doi-reference
Can the promise of radionuclide cardiac innervation imaging be fulfilled?
10.1007/s12350-021-02866-6 · doi-reference
Stable delineation of the ischemic area by the PET perfusion tracer 18F-fluorobenzyl triphenyl phosphonium after transient coronary occlusion
10.2967/jnumed.110.085993 · doi-reference
Flurpiridaz F18: a new era in nuclear cardiac imaging – the first FDA-approved radiotracer in 30 years
10.1097/ms9.0000000000004032 · doi-reference
18F labeled myocardial perfusion PET: new precision in cardiac imaging
10.1016/j.tcm.2025.03.008 · doi-reference
Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent
10.1016/j.nuclcard.2007.07.009 · doi-reference
Emerging PET tracers in cardiac molecular imaging
10.1007/s40119-022-00295-1 · doi-reference
Tracers for cardiac imaging: targeting the future of viable myocardium
10.3390/pharmaceutics15051532 · doi-reference
Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients with severe coronary artery disease: a prospective, self-controlled study
10.1007/s12350-021-02749-w · doi-reference
An optimized fast track protocol to enhance the image quality of 18F-FDG PET myocardial viability imaging in diabetic CAD patients: a randomized controlled trial
10.1007/s11307-025-02074-5 · doi-reference
New opportunities for nuclear cardiology with total-body positron emission tomography/computed tomography
10.1016/j.nuclcard.2026.102652 · doi-reference
Multiparametric cardiac 18F-FDG PET in humans: pilot comparison of FDG delivery rate with 82Rb myocardial blood flow
10.1088/1361-6560/ac15a6 · doi-reference
A methodology to measure glucose metabolism by quantitative analysis of PET images
10.1007/s41666-024-00172-7 · doi-reference
Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy
10.1007/s12350-018-1395-4 · doi-reference
Multiparametric cardiac 18F-FDG PET in humans: kinetic model selection and identifiability analysis
10.1109/trpms.2020.3031274 · doi-reference
Evaluation of the diagnostic value of joint PET myocardial perfusion and metabolic imaging for vascular stenosis in patients with obstructive coronary artery disease
10.1007/s12350-020-02160-x · doi-reference
Deep learning in quantitative PET myocardial perfusion imaging: a study on cardiovascular event prediction
10.1016/j.jcmg.2019.08.009 · doi-reference
Low-dose PET image noise reduction using deep learning: application to cardiac viability FDG imaging in patients with ischemic heart disease
10.1088/1361-6560/abe225 · doi-reference
Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT
10.1007/s00259-021-05341-z · doi-reference
PET-based artificial intelligence applications in cardiac nuclear medicine
10.4414/smw.2022.w30123 · doi-reference
Artificial intelligence and cardiac PET/computed tomography imaging
10.1016/j.cpet.2021.06.011 · doi-reference
The future of molecular imaging
10.1016/j.jcmg.2011.05.003 · doi-reference
Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction
10.1016/j.jcmg.2015.09.008 · doi-reference
Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction
10.1161/circimaging.110.961854 · doi-reference
Applications of pet-mri in cardiovascular disorders
10.1016/j.cpet.2020.06.007 · doi-reference
Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction
10.1007/s12350-017-0918-8 · doi-reference
Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results
10.1097/mnm.0000000000000680 · doi-reference
Hybrid PET/MR imaging for the prediction of left ventricular recovery after percutaneous revascularisation of coronary chronic total occlusions
10.1007/s00259-020-04877-w · doi-reference
Prospective evaluation of 18f-fdg uptake in post-ischemic myocardium by simultaneous pet/mri as a prognostic marker of functional outcome
10.1161/circimaging.115.004316 · doi-reference
Hybrid PET/MR imaging of the heart: feasibility and initial results
10.1148/radiol.13130231 · doi-reference
PET-MRI of coronary artery disease
10.1002/jmri.28554 · doi-reference
2018 ESC/EACTS guidelines on myocardial revascularization
10.1093/eurheartj/ehy394 · doi-reference
Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol
10.1093/eurheartj/ehi747 · doi-reference
F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization
10.1016/j.mri.2003.07.006 · doi-reference
Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction
10.1001/jamacardio.2023.3803 · doi-reference
Alternative Imaging Modalities in ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial
10.1186/1745-6215-14-218 · doi-reference
Myocardial viability and survival in ischemic left ventricular dysfunction
10.1056/nejmoa1100358 · doi-reference
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial
10.2967/jnumed.109.065938 · doi-reference
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial
10.1016/j.jcmg.2009.02.017 · doi-reference
